ZOONF (Zoono Group) Cash And Cash Equivalents : $0.45 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zoono Group Cash And Cash Equivalents?

Zoono Group's quarterly cash and cash equivalents increased from Dec. 2023 ($0.09 Mil) to Jun. 2024 ($1.19 Mil) but then stayed the same from Jun. 2024 ($1.19 Mil) to Dec. 2024 ($0.45 Mil).

Zoono Group's annual cash and cash equivalents declined from Jun. 2022 ($2.32 Mil) to Jun. 2023 ($0.51 Mil) but then increased from Jun. 2023 ($0.51 Mil) to Jun. 2024 ($1.19 Mil).

Zoono Group Cash And Cash Equivalents Historical Data

The historical data trend for Zoono Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoono Group Cash And Cash Equivalents Chart

Zoono Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Cash And Cash Equivalents

Get a 7-Day Free Trial

6.66

3.49

2.32

0.51

1.19

Zoono Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial															0.29	0.51	0.09	1.19	0.45

Zoono Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Zoono Group (OTCPK:ZOONF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Zoono Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Zoono Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoono Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zoono Group Ltd (OTCPK:ZOONF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

ZNO:Australia

Address

24 Bishop Dunn Place, Unit 3, Flatbush, Auckland, NTL, NZL, 2013

Website

https://www.zoono.com

Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products, and mold remediation treatments. Geographically, it derives a majority of its revenue from Australasia, Asia, the United States, and India, and also has a presence in the United Kingdom and Europe.

Zoono Group Headlines

From GuruFocus

Half Year 2022 Zoono Group Ltd Earnings Call Transcript

By GuruFocus Research • 02-15-2024